France Parkinsons Disease Market (2025-2031) | Size & Revenue, Value, Share, Forecast, Growth, Trends, Segmentation, Companies, Industry, Analysis, Outlook, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 France Country Macro Economic Indicators

3.2 France Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 France Parkinsons Disease Market - Industry Life Cycle

3.4 France Parkinsons Disease Market - Porter's Five Forces

3.5 France Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 France Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 France Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 France Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 France Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in France leading to higher prevalence of Parkinson's disease

4.2.2 Rising awareness about Parkinson's disease and its early diagnosis and treatment

4.2.3 Advancements in medical research and technology for better management of Parkinson's disease

4.3 Market Restraints

4.3.1 High cost of Parkinson's disease medications and treatments

4.3.2 Limited accessibility to specialized healthcare services for Parkinson's patients in certain regions

6.1 France Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 France Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 France Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 France Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 France Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 France Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 France Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 France Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 France Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 France Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 France Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 France Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 France Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 France Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 France Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 France Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 France Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 France Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 France Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 France Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 France Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 France Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 France Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 France Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 France Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7.1 France Parkinsons Disease Market Export to Major Countries

7.2 France Parkinsons Disease Market Imports from Major Countries

8.1 Number of clinical trials conducted for Parkinson's disease treatments in France

8.2 Percentage increase in early diagnosis rates of Parkinson's disease

8.3 Adoption rate of new technologies and treatments for Parkinson's disease in healthcare facilities

9.1 France Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 France Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 France Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 France Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 France Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10.1 France Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 France Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters